BETHANY GILLING: Open Payments
NPI 1043901978 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 8 payments from 7 companies in 2025. Trend: 2023 $41 · 2024 $45 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $110 |
| Biogen, Inc. | 2 | $40 |
| Organon LLC | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| PFIZER INC. | 1 | $20 |
| CooperSurgical, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: QULIPTA, ZURZUVAE, NEXPLANON, Mirena, COMIRNATY, Paragard T 380A, Veozah.
Industry payments across MI — which companies pay providers there.
